| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-18 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-10 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.0002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |